Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | European Molecular Biology Laboratory | 30 |
| 2 | Sanofi SA | 25 |
| 3 | Caribou Biosciences Inc | 24 |
| 4 | Incyte Corp | 17 |
| 5 | Moderna Inc | 13 |
| 6 | Nestle SA | 13 |
| 7 | Roche Holding AG | 11 |
| 8 | Agency for Science, Technology and Research | 10 |
| 9 | Beam Therapeutics Inc | 9 |
| 10 | Cocrystal Pharma Inc | 9 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 262 |
| 2 | C12N | Microorganisms, enzymes | 257 |
| 3 | A61P | Therapeutic activity (drug indications) | 242 |
| 4 | C07K | Peptides | 173 |
| 5 | G01N | Investigating / analysing materials | 67 |
| 6 | C12Y | Enzyme nomenclature (EC numbers) | 62 |
| 7 | C07D | Heterocyclic compounds | 56 |
| 8 | Y02A | Climate change adaptation | 56 |
| 9 | C12Q | Measuring/testing involving enzymes | 46 |
| 10 | C12P | Fermentation, enzyme processes | 40 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS | 2014 | Caribou Biosciences Inc | 336 |
| Human application of engineered chimeric antigen receptor (CAR) T-cells | 2017 | The University of Texas System | 97 |
| Kits and methods for generating 5′ capped RNA | 2014 | 97 | |
| Compositions and methods of nucleic acid-targeting nucleic acids | 2016 | Caribou Biosciences Inc | 74 |
| Intracellular genomic transplant and methods of therapy | 2019 | Government of the United States of America | 35 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Edward Darżynkiewicz | University of Warsaw | 6 |
| 2 | Jacek Jemielity | University of Warsaw | 5 |
| 3 | Robert E. Rhoads | New York University | 5 |
| 4 | Dixie J. Goss | Hunter College | 5 |
| 5 | Joanna Zuberek | University of Warsaw | 4 |
| 6 | Ryszard Stolarski | University of Warsaw | 3 |
| 7 | Joanna Kowalska | University of Warsaw | 3 |
| 8 | Janusz Stȩpiński | University of Warsaw | 3 |
| 9 | Michal Shapira | Ben-Gurion University of the Negev | 2 |
| 10 | Nahum Sonenberg | McGill University | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events | 2005 | 1251 | RNA and protein synthesis mechanisms |
| The structural basis for cap binding by influenza virus polymerase subunit PB2 | 2008 | 493 | Influenza Virus Research Studies |
| Biophysical Studies of eIF4E Cap-binding Protein: Recognition of mRNA 5′ Cap Structure and Synthetic Fragments of eIF4G and 4E-BP1 Proteins | 2002 | 386 | PI3K/AKT/mTOR signaling in cancer |
| Identification of a protein linked to the genomic and subgenomic mRNAs of feline calicivirus and its role in translation. | 1997 | 164 | Viral gastroenteritis research and epidemiology |
| The 5′-7-Methylguanosine Cap on Eukaryotic mRNAs Serves Both to Stimulate Canonical Translation Initiation and to Block an Alternative Pathway | 2010 | 155 | RNA and protein synthesis mechanisms |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of 7-Methylguanosine 5'-triphosphate?
Which organizations hold the most patents related to this compound?
What research areas are most commonly associated with patents on this compound?
What is the recent patent activity trend for this compound?
Which researchers have published the most work on this compound?